Umwirondoro w'isosiyete
Innovita Biological Technology Co., Ltd. (hamwe n’ibigo biyishamikiyeho, hamwe bizwi ku izina rya “INNOVITA”,) ni isosiyete ikora ibijyanye n’ibinyabuzima yibanda ku bushakashatsi, iterambere, umusaruro no kugurisha ibicuruzwa bya virusi isuzuma POCT. Igizwe na Innovita (Tangshan) , Innovita (Beijing) na Innovita (Guangzhou).
Yashinzwe mu 2006
Gushiraho ibigo bya R&D i Beijing na Guangzhou, hamwe n’umusaruro i Qian'an, Hebei
Umwirondoro w'isosiyete
INNOVITA yashinzwe mu 2006, yubatsemo uburyo butandatu bwa tekiniki nka antigen & antibody itegura, umuco wa virusi, zahabu ya colloidal, ELISA, fluorescence chromatografiya, immunofluorescence, kandi ikora gahunda y’ubushinwa n’ikoranabuhanga rikomeye ry’ubushakashatsi mu rwego rw’ubushakashatsi bw’indwara zikomeye zanduza ndetse na benshi indi mishinga yubuzima rusange.Uretse ibyo, INNOVITA ifite patenti zirenga icumi zo guhanga no gushyiraho ikigo cya Beijing R&D, ikigo cya Guangzhou R&D, ikigo cya Hebei.Hamwe n'amahugurwa manini asukuye, no gushyiraho zahabu ya colloidal, ELISA, chromatografiya ya fluorescence, PCR, imirongo ikora immunofluorescence, INNOVITA yabonye CE na ISO13485.
Kugeza ubu, ibicuruzwa bya INNOVITA birimo ibizamini byo gupima ubuhumekero, ibizamini byuburumbuke, ibizamini bya hepatite, ibizamini bya TORCH, ibizamini byumutima, imitsi yimpyiko nibindi.Urusobe rwo kugurisha rwakwirakwije intara n’uturere twose two mu Bushinwa, bikwira no mu majyepfo y’amajyepfo ya Aziya, Uburasirazuba bwo hagati, Afurika, Amerika y'Epfo, Umuryango w’ubumwe bw’ibihugu by’Uburayi ndetse no mu tundi turere two mu mahanga.INNOVITA yubahiriza filozofiya yubucuruzi ishingiye kubakiriya, kandi ikorera abakiriya nibicuruzwa byukuri kandi byoroshye.Abakiriya bakeneye ni ugukurikirana INNOVITA.
Inzira y'Iterambere
Amashami
Beijing R&D & Centre
Ishyirwaho:2006
Icyerekezo:R&D, gukora, kwamamaza ibicuruzwa biva muri vitro, harimo urubuga nka immunodiagnose, gusuzuma molekile, hamwe na chip chip.
Qian'an Gukora & Logistic Centre
Ishyirwaho:2011
Ikigo:Ubuso bungana na hegitari 150, hafi 8000 area ahakorerwa amahugurwa, hashyizweho imirongo myinshi yo gukora zahabu ya colloidal, ELISA, PCR.
Icyemezo:ISO 13485, CE, FDA, NMPA, nibindi.
Guangzhou R&D Centre
Ishyirwaho:2020
Icyerekezo:R&D ya tekinoroji ya IVD
Amahuriro
Umuyoboro wo kwamamaza
Nyuma yimyaka myinshi yiterambere, Innovita imaze kugira umuyoboro wuzuye wo kugurisha no gutanga serivisi, hamwe numuyoboro ugurisha ukorera mu ntara 32 n’uturere twose two mu Bushinwa, kandi byohereje ku masoko yisi yose nko mu majyepfo y’iburasirazuba bwa Aziya, Uburasirazuba bwo hagati, Afurika, Amerika y'Epfo, Uburayi, n'ibindi.
Innovita 2019-nCoV Ab Ikizamini cyerekanwe kumurongo wihutirwa wimiti nibikoresho byubuvuzi
Ku ya 28 Gashyantare 2020, Minisitiri w’intebe Li Keqiang yagenzuye urubuga rwihutirwa rw’imiti n’ibikoresho by’ubuvuzi bya COVID-19.Ikizamini cya Innovita 2019-nCoV Ab cyerekanwe nkikizamini cya mbere cya NMPA cyemewe na IgM / IgG combo antibody, byatangajwe kuri CCTV.
Innovita 2019-nCoV Ab Ikizamini cyitiriwe Academic Zhong Nanshan
● Ku gicamunsi cyo ku ya 23 Gashyantare 2020, Umwarimu Zhong Nanshan yatangaje mu nama yagiriye kure i Guangzhou hamwe n’itsinda ry’ubuvuzi rya Guangdong ryihutira gufasha Jingzhou ko Ikigo cy’igihugu cy’ibicuruzwa by’ubuvuzi cyemeje ibikoresho bibiri by’ibizamini bya 2019-nCoV, kimwe muri byo kikaba ari kimwe. byakozwe na Innovita (Tangshan) Biologiya Technology Co., Ltd.
Kit Igikoresho gikoresha uburyo bwa zahabu ya colloidal, ishobora kumenya antibody ya lgM mumubiri wumurwayi.Antibody ya lgM irashobora kumenyekana kumunsi wa 7 wanduye umurwayi cyangwa kumunsi wa 3 wo gutangira, bikaba bifasha cyane mugusuzuma umurwayi.Zhong Nanshan yagize ati: "Abarwayi barashobora kumenyekana vuba kugira ngo basuzume neza. Ibi birashobora kudufasha gutandukanya abantu basanzwe n'abanduye."